05/21/2024
A North Carolina biotech research firm is expanding its novel therapeutic and drug development efforts to Cleveland.
Lamassu Biotech said it’s launching corporate offices in the city. The company is collaborating with Cleveland Clinic as it gears up to launch a phase 1/2a clinical trial for a genetically targeted oncology program that would offer an alternative to invasive therapies.
CLICK HERE to read the full story from Crain’s Cleveland Business.